Skip navigation.
Home | About Us | Contact Us
Rick Scott, Governor
Florida Department of Corrections, Secretary Michael D. Crews

Florida Department of Corrections
Timothy H. Cannon, Interim Secretary

Program Services

Bureau of Substance Abuse
Program Services

Pam Denmark,
Bureau Chief
(850) 410-4430
SunCom 210-4430

Additional Contact
Information

The Bureau of Substance Abuse Program Services provides in-prison and community-based services. Institutional programs include the following: identification of offenders who have substance abuse problems, treatment services prioritized and delivered based on the severity of addiction, the amount of sentence time remaining, and adjustment while incarcerated; comprehensive services (delivered by department staff, contracted vendors or a combination) ranging from psycho-education to intensive residential treatment, relapse prevention, and transitional services. Community based programs include the following: long-term secure residential drug beds, non-secure residential drug beds, diversion center programs, and outpatient substance abuse treatment; court-ordered community alternatives to incarceration; and transitional services.

Overall Recommitment Rates for all Successful Completions
for Residential Community-Based Substance Abuse Programs
Sept. 1, 1991 - June 30, 1999

Chart of Recommitment rates.  Secre Prison 16.5% Supervision 17.3% No Recommitment 66.1%.  NonSecure Prison 17.0%, Supervision 19.5% No Recommitment 63.3%.


Community Corrections Statewide
Offender Drug Testing
Over Five Years

Corrections Drug Testing - Numbers rose from 317,261 in 94-95 to 371,314 in 98-99.


Total Treatments for
Community-Based Substance Abuse Programs
FY 1998-99
Total = 31,694

Total Treatments for Substance Abuse Programs.  83% Outpatient, 14% NonSecure, 3% Secure.


Total Treatments for
Institutional Substance Abuse Programs
FY 1998-99
Total = 17,503

Total Treatments for Institutional Substance Abuse Programs.  34% Long-Temr TC, 18% Re-Entry, 25% Prevention/Education, 20% Intensive Outpatient, 3% Co-Ocurring TC.